Marked variation of thymidylate synthase and folylpolyglutamate synthetase gene expression in human colorectal tumors

Oncology Research

Volumn 11, Issue 9, 1999, Pages 437-445

  Mini, Enrico ^a   Biondi, Cristina ^a   Morganti, Maria ^a   Napoli, Cristina ^a   Mazzoni, Paolo ^a   Cianchi, Fabio ^a   Tonelli, Francesco ^a   Cortesini, Camillo ^a   Capaccioli, Sergio ^a   Ficari, Ferdinando ^a   Quattrone, Alessandro ^a   Rossi, Susanna ^a   Mazzei, Teresita ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

5 Fluorouracil; Colorcctal carcinoma; Folylpolyglutamatc synthetasc; Resistance; Thymidylatc synthase

Indexed keywords

FOLYLPOLYGLUTAMATE SYNTHASE; PEPTIDE SYNTHASE; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; COLORECTAL TUMOR; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MIDDLE AGED; MORTALITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PEPTIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDYLATE SYNTHASE;

EID: 0033292028     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Mini, E.; Trave, F.; Rustum, Y. M.; Bertino, J. R. Enhancement of the antitiimor effects of 5-fluorouracil by folinic acid. Pharmacol. Ther. 47:1-19;1990.
2. Sohrero, A. F.; Aschele, C.; Bcrtino, J. R. Fluorouracil in colorectal cancer. A tale of two drugs: Implications for biochemical modulation. J. Clin. Oncol. 15:368-381; 1997.
3. Zaniboni, A. Adjuvant chemotherapy in colorcctal cancer with high-dose leucovorin and fluorouracil: Impact on disease-free survival and overall survival. J. Clin. Oncol. 15:2432-2441; 1997.
4. Swain, S. M.; Lippman, M. E.; Egan, E. F.; Drake, J. C.; Steinberg, S. M.; Allegra, J. C. Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer. J. Clin. Oncol. 7:890-899; 1989.
5. Peters, G. J.; van Groeningen, C. J.; Laurenssc, E. J.; Pincdo, H. M. Thymidylate synthase from untreated human colorectal cancer and colonie mucosa: Enzyme activity and inhibition by 5-fluoro2'-deoxyuridine-5'-monophosphate. Eur. J. Cancer 27:263-267; 1991.
6. Trave, F.; Rustum, Y. M.; Petrelli, N. J.; Herrera, L.; Mittelman, A.; Frank, C.; Creaven, P. J. Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma. J. Clin. Oncol. 6:1184-1191; 1988.
7. Spears, C. P.; Gustavsson, B. G.; Berne, M.; Prosing, R.; Bernstein, L.; Hayes, A. A. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil. Cancer Res. 48: 5894-5900; 1988.
8. Santi, D. V.; McHenry, C. S.; Sommer, H. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry 13:471-481; 1974.
9. Radparvar, S.; Houghton, P. J.; Houghton, J. A. Effect of polyglu-tamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fIuoro-2′-dcoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenograft. Biochem. Pharmacol. 38: 335-342; 1989.
10. McGuire, J. J.; Bertino, J. R. Enzymatic synthesis and function of folylpolyglutamates. Mol. Cell. Biochem. 38:19-48; 1981.
11. Bapat, A. R.; Zarow, C.; Danenberg, P. V. Human leukemic cells resistant to 5-fluoro-2'deoxyuridine contain a thymidylate synthetase with lower affinity for nucleotides. J. Biol. Chem. 258:4130-4136; 1983.
12. Davis, S. T.; Berger, S. H. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2′-deoxyuridine. Mol. Pharmacol. 43:702-708; 1993.
13. Copur, S.; Aiba, K.; Drake, J. C.; Allegra, C. J.; Chu, E. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Biochem. Pharmacol. 49:1419-1426; 1995.
14. Kessel, D.; Hall, T. C.; Wodinsky, I. Nucleotide formation as a determinant of 5-fluorouracil response in mouse leukemias. Science 154:911-913; 1966.
15. Reichard, P.; Sköld, O.; Klein, G.; Rcvész, L.; Magnusson, P. H. Studies on resistance against 5-fluorouracil. I Enzymes of the uracil pathway during development of resistance. Cancer Res. 22: 235-243; 1962.
16. Mulkins, M. A.; Heidelberger, C. Biochemical characterization of fluoropyrimidine-rcsistant murine leukemic cell lines. Cancer Res. 42:965-973; 1982.
17. Ardalan, B.; Cooney, D. A.; Jayaram, H. N.; Carrico, C. K.; Glazer, R. I.; MacDonald, J.; Schein, P. S. Mechanism of sensitivity and resistance of murine tumors to 5-fluorouracil. Cancer Res. 40:1431-1437; 1980.
18. Fcrnandes, D. J.; Cranford, S. K. Resistance of CCRF-CEM cloned sublines to 5-fluorodcoxyuridinc associated with enhanced phosphatasc activities. Biochem. Pharmacol. 34:125-132; 1985.
19. Beck, A.; Etienne, M. C.; Cheradame, S.; Fischcl, J. L.; Formento, P.; Renée, N; Milano, G. A role for dihydropyrimidine dehydrogcnase and thymidylate synthase in tumor sensitivity to fluorouracil. Eur. J. Cancer 30A: 1517-1522; 1994.
20. Canman, C. E.; Lawrence, T. S.; Shewach, D. S.; Tang, H.-Y.; Maybaum, J. Resistance to fluorodeoxyuridine-induced DNA damage and cytotoxicity correlates with an elevation of deoxyuridine triphosphatase activity and failure to accumulate dcoxyuridine triphosphate. Cancer Res. 53:5219-5224; 1993.
21. Wang, F. S.; Aschele, C.; Sobrero, A.; Chang, Y. M.; Bertino, J. R. Decreased folylpolyglutamate synthetase expression: A novel mechanism of fluorouracil resistance. Cancer Res. 53:3677-3680; 1993.
22. Romanini, A.; Lin, J. T.; Niedzwiecki, D.; Bunni; M.; Priest, D. G.; Bertino, J. R. Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin. Cancer Res. 51: 789-793; 1991.
23. Peters, G. J.; van der Wilt, C. L.; van Groeningen, C. J.; Smid, K.; Meijer, S.; Pinedo, H. M. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: Implications for treatment with fluorouracil. J. Clin. Oncol. 12:2035-2042; 1994.
24. Horikoshi, T.; Danenberg, K. D.; Stadibauer, T. H.; Volkenandt, M.; Shea, L. L. C.; Aigner, K.; Gustavsson, B.; Leichman, L.; Frösing, R.; Ray, M.; Gibson, N. W.; Spears, C. P.; Danenberg, P. V. Quantitation of ihymidylate synthase, dihydrofolate reductasc and DT-diaphorasc gene expression in human tumors using polymerase chain reaction. Cancer Res. 52:108-116; 1992.
25. Johnston, P. G.; Lenz, H. J.; Leichman, C. G.; Danenberg, K. D.; Allegra, C. J.; Danenberg, P. V.; Leichman, L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res. 55:1407-1412; 1995.
26. Leichman, C. G.; Lenz, H. J.; Leichman, L.; Danenberg, K.; Baranda, J.; Groshen, S.; Boswell, W.; Metzger, R.; Tan, M.; Danenberg, P. V. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J. Clin. Oncol. 15:3223-3229; 1997.
27. Johnston, P. G.; Fisher, E. R.; Rockette, H. E.; Fisher, B.; Wolmark, N.; Drake, J. C.; Chabner, B. A.; Allegra, C. J. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J. Clin. Oncol. 12:2640-2647; 1994.
28. Jansen, G.; Schornagel, J. H.; Kathmann, J.; Westerhof, G. R.; Hordijk, G-J.; van der Laan, B. F. Measurement of folylpolyglutamate synthetase activity in head and neck squamous carcinoma cell lines and clinical samples using new rapid separation procedure. Oncol. Res. 4:299-305; 1992?
29. van der Wilt, C. L.; Cloos, J.; de Jong, M.; Pinedo, H. M.; Peters, G. J. Screening of colon tumor cells and tissues for folylpolyglutamatc synthetase activity. Oncol. Res. 7:317-321; 1995.
30. Chazal, M.; Cheradame, S.; Formento, J. L.; Francoual, M.; Formento, P.; Etienne, M. C.; Francois, E.; Richelime, H.; Mousseau, M.; Letoublon, C; Pczct, D.; Cure, H.; Seitz, J. F.; Milano, G. Decreased folylpolyglutamate synthetase (FPGS) activity in tumors resistant to fluorouracil-folinic acid treatment: Clinical data. Clin. Cancer Res. 3:553-557; 1997.
31. Lenz, H. J.; Danenberg, K.; Schnicdcrs, B.; Göker, E.; Peters, G. J.; Garrow, T.; Shanc, B.; Bcrtino, J. R.; Danenberg, P. V. Quantitative analysis of folypolyglutamate synthetase gene expression in tumor tissue by the polymerasc chain reaction: Marked variation of expression among leukemia patients. Oncol. Res. 6:329-335; 1994.
32. Mullis, K.; Faïoona, F.; Scharf, S.; Saiki, R. K.; Horn, G. T.; Erich. H. A. Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction. Cold Spring Harbor Symp. Quant. Biol. 51:263-273; 1986.
33. Chomczynski, P.; Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159; 1987.
34. Soubeyran, P.; Cababukksa, F.; Lee, M. S. Analysis of the expression of hybrid gene bcl-2/IgH in follicular lymphomas. Blood 81: 122-127; 1993.
35. Miller, S. A.; Dykes, D. D.; Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:I2f5; 1988.
36. Takeishi, K.; Kaneda, S.; Ayusawa, D.; Shimizu, K.; Gotoh, O.; Seno, T. Nuclcotide sequence of a functional cDNA for human thymidylatc symhase. Nucleic Acids Res. 13:2035-2043; 1987.
37. Garrow, T. A.; Admon, A.; Shane, B. Expression cloning of a human cDNA encoding folypoly(y-glutamate) synthetase and determination of its primary structure. Proc. Natl. Acad. Sci. USA 89:9151-9155; 1992.
38. Ng, S-Y.; Gunning, P.; Eddy, R.; Ponte, P.; Leavitt, J.; Shows, T.; Kedes, L. Evolution of the functional human β-actin gene and its multipscudogcne family: Conservation of non coding regions and chromosomal dispersion of pseudogenes. Mol. Cell. Biol. 5:2720-2732; 1985.
39. Peters, G. J.; van der Wilt, C. L.; van Tricst, B.; Codacci-Pisanclli, G.; Johnston, P. G.; van Groeningen. C. J.; Pinedo, H. M. Thymidylate synthase and drug resistance. Eur. J. Cancer 31 A: 1299-1305; 1995.
40. Aherne, G. N.; Hardcastle, A.; Newton, R. Measurement of human thymidylate synthase (hTS) in cell lines using ELISA. Ann. Oncol. 3(Suppl.):77; 1992.
41. Johnston, P. G.; Drake, J. C.; Steinberg, S. M.; Allegra, C. J. Quantitation of thymidylate synthase in human tumors using an ultrasensitive enzyme-linked immunoassay. Biochem. Pharmacol. 45:2483-2486; 1993.
42. Johnston, P. J.; Drake, J. C.; Trepcl, J.; Allegra, C. J. linmunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and-resistant human cancer cell lines. Cancer Res. 52:4306-4312; 1992.
43. Alexander, H. R.; Grem, J. L.; Hamilton, J. M.; Pass, H. I.; Hong, M.; Fraker, D. L.; Steinberg, S. M.; McAtee, N.; Allegra, C. J.; Johnston, P. G. Thymidylate synthase protein expression. Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma. Cancer J. Sci. Am. 1:49-54; 1995.
44. Lenz, H. J.; Hayashi, K.; Salonga, D.; Danenberg, K. D.; Danenberg, P. V.; Metzger, R.; Banerjee, D.; Bertino, J. R.; Groshen, S.; Leichman, L. P.; Leichman, C. G. p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival. Clin. Cancer Res. 4:1243-1250; 1998.
45. Lenz, H. J.; Leichman, C. G.; Danenberg, C. D.; Danenberg, P. V.; Groshen, S.; Cohen, H.; Laine, L.; Crookes, P.; Silberman, H.; Baranda, J.; Garcia, Y.; Li, J.; Leichman, L. Thymidylate synthase mRNA level in adcnocarcinoma of the stomach: A predictor for primary tumor response and overall survival. J. Clin. Oncol. 14: 176-182; 1996.
46. Johnston, P. G.; Mick, R.; Recant, W.; Bchan, K. A.; Dolan, M. E.; Ratain, M. J.; Bcckmann, E.; Weichselhaum, R. R.; Allegra, C. J.; Yokes, E. E. Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer. J. Nail. Cancer Inst. 89:308-313; 1997.
47. Lenz, H. J.; Danenberg, K. D.; Leichman, C. G.; Florentine, B.; Johnston, P. G.; Groshcn, S.; Zhou, L.; Xiong, Y. P.; Danenberg, P. V.; Leichman, L. P. p53 and thymidylate synthase expression in untreated stage II colon cancer: Associations with recurrence, survival and site. Clin. Cancer Res. 4:1227-1234; 1998.
48. Pestalozzi, B. C.; Pcterson, H. F.; Gelber, R. D.; Goldhirsch, A.; Gusterson, B. A.; Trihia, H.; Lindtner, J.; Cortcs-Funcs, H.; Simmoncini, E.; Byrne, M. J.; Golouh, R.; Rudcnstam, C. M.; Castiglione-Gcrtsch, M.; Allcgra, C. J.; Johnston, P. G. Prognostic importance of thymidylate synthase expression in early breast cancer. J. Clin. Oncol. 15:1923-1931; 1997.
49. Findlay, M. P.; Cunningham, D.; Morgan, G.; Clinton, S.; Hardcastle, A.; Ahcrnc, G. W. Lack of correlation between thymidylate synthase levels in primary colorcctal tumours and subsequent response to chemotherapy. Br. J. Cancer 75:903-909; 1997.
50. Chcradamc, S.; Eticnne, M. C.; Formcnto, P.; Schneider, M.; Dassonville. O.; Demard, F.; Milano, G. Tumoral-reduccd folates and clinical resistance to fluorouracil-bascd treatment in head and neck cancer patients. J. Clin. Oncol. 15:2604-2610; 1997.
51. Danenberg, K.; Salonga, D.; Park, J. M.; Leichman, C. G.; Leichman, L.; Johnson, M.; Diasio, R.; Danenberg, P. Dihydropyrimidine dehydrogcnasc (DPD) and ihymidylate synthase (TS) gene expressions identify a high percentage of colorectal tumors responding to 5-fluorouracil (5-FU). Proc. Am. Soc. Clin. Oncol. 17:258a; 1998.
52. Metzger, R.; Danenberg, K.; Leichman, C. G.; Salonga, D.; Schwanz, E. L.; Wadlcr, S.; Lenz, H. J.; Groshen, S.; Leichman, L.; Danenberg, P. V. High basal level gene expression of thymidine phosphorylase (platelet-derived endothclial cell growth factor) in colorcctal tumors is associated with nonresponse to 5-fluoroiiracil. Clin. Cancer Res. 4:2371-2376; 1998.
53. Yin, M. B.; Zakrzewski, S. F.; Hakala, M. T. Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil. Mol. Pharmacol. 23:190-197; 1983.
54. McCloskey, D. E.; McGuire, J. J.; Rüssel, C. A.; Rowan, B. G.; Bcrtino, J. R.; Pizzorno, G.; Mini, E. Decreased folylpolyglutamate synthetase activity as a mechanism of methotrcxate resistance in CCRF-CEM human leukemia subline. J. Biol. Chem. 266: 6181-6187;1991.
55. Pizzorno, G.; Mini, E.; Coronncllo, M.; McGuire, J. J.; Moroson, B. A.; Cashmore, A. R.; Drcyer, R. N.; Lin, J. T.; Mazzei, T.: Pcriti, P.; Bcrtino, J. R. Impaired polyglutamylation of methotrexatc as a cause of resistance of CCRF-CEM cell after short-term, hiah dose treatment with this drug. Cancer Res. 48:2149-2155; 1988.
56. McGuire, J. J.; Russell, C. A. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines. Oncol. Res. 10:193-200; 1998.
57. Jackman, A. L.; Calvert, A. II. Folatc-bascd thymidylate synthase inhibitors as anticancer drugs. Ann. Oncol. 6:871-881; 1995.
58. Rustum. Y. M.; Harstrick, A.; Cao, S.; Vanhocfer, U.; Yin, M. B.; Wilke, II.; Sccber, S. Thymidylate synthase inhibitors in cancer therapy: Direct and indirect inhibitors. J. Clin. Oncol. 15:389-400; 1997.
59. Cunningham, D. Mature results from three large controlled studies with rahilrexed (Tomudex'). Br. J. Cancer 77(Suppl. 2): 15-21; 1998.
60. Farrugia, D. C.; Ford, H.; Cunningham, D.; McVicar, D.; Aherne, G. wT; Hardcastle, A.; McCarthy, K.; Mitchell, F.; Danenberg. P. V.; Jackman, A. L.; Danenberg, K. Genomic study of patients with advanced colorectal cancer treated with raltitrexed (Tomudcx'). Proc. Am. Soc. Clin. Oncol. 18:268a; 1999.